WEBINAR | Scaling AI-Assisted Infection Prevention: CLABSI Case Review and Beyond

John Doerpinghaus, Director; Jathan Merkel, Managing Consultant; and Avery Ashby, Managing Director, Impact Advisors. Many health systems are testing Generative AI (GenAI) and large language models (LLMs), but pilots often stall before they help front-line teams. In this webinar, Impact Advisors shares how it implemented GenAI within a leading health system to support central line-associated bloodstream infection (CLABSI) case review, cutting down manual chart scanning while keeping clinicians in charge of the final decision. The session will walk through what was actually built, how infection prevention and quality leaders were involved, and how governance and change management were handled. We will also touch on how the same approach can be adapted for other healthcare-associated infections (HAIs) and selected quality measures, including those used in programs such as U.S. News & World Report.